Teva stock plummets 18% after rough quarter in US generic drug market
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters | Markets Insider
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | Fierce Pharma
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits - CNN
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva Pharm to lay off a quarter of workforce, suspends dividend
Cipla, Aurobindo Pharma acquire products divested by Teva in US | Mint
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
Teva buys Anda for $500 million - ISRAEL21c
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
/s3.amazonaws.com/arc-authors/reuters/75c45489-f2d2-466a-9429-aeeb9ef3b6f1.png "Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters")
Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva settles shareholder lawsuit over generic drug | Business Insurance
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha
Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva Pharmaceutical loses another CEO, leaving investors to guess what's next | Mint
US Supreme Court sides with Teva in drug dispute
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LZGVDDQWGFNKPLS2GEX4W3DBA4.jpg "Teva lied about opioid role, New York says | Reuters")
Teva lied about opioid role, New York says | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva could pay $3.6b to settle opioid dispute - report - Globes
